Sodium Acetate Injection
Last Updated: July 3, 2017
Status: Current
Sodium Acetate Injection
Products Affected - Description
-
Sodium acetate injection, Fresenius Kabi
4 mEq/mL, 100 mL vial, 25 count (NDC 63323-0032-61)
Sodium acetate injection, Pfizer
2 mEq/mL, 20 mL vial, 25 count (NDC 00409-7299-73)
2 mEq/mL, 20 mL vial, 25 count (NDC 00409-7299-73)
2 mEq/mL, 50 mL vial, 25 count (NDC 00409-3299-05)
2 mEq/mL, 100 mL vial, 25 count (NDC 00409-3299-06)
2 mEq/mL, 100 mL vial, 25 count (NDC 00409-3299-06)
Reason for the Shortage
-
- American Regent has had sodium acetate on long-term back order for several years.
- Fresenius Kabi has sodium acetate on shortage due to increased demand.
- Pfizer has sodium acetate on shortage due to manufacturing delays.
Available Products
-
There is insufficient supply for usual ordering
Estimated Resupply Dates
-
- Fresenius Kabi has sodium acetate 4 meq/mL 100 mL vials on back order and the company estimates a release date of mid-July 2017.
- Pfizer has sodium acetate 2 meq/mL 20 mL, 50 mL and 100 mL vials on back order and the company estimates a release date of August 2017 for the 20 mL vials and late-July 2017 for the 50 mL and 100 mL vials.
Related Shortages
| Sodium Bicarbonate Injection | Current |
| Sodium Lactate Injection | Resolved |
| Tromethamine Injection | No Longer Available |
Updated
July 3, June 21, 9 and 6, May 11, 2017, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
